A new report has found that emerging companies, most with no presence in Australia, are responsible for over 90 per cent of gene, cell and nucleotide therapies currently in late-stage pipelines.

Monash Health has become the second hospital to join the Rhythm Biosciences (ASX:RHY) prospective clinical trial of ColoSTAT - its blood test for the early detection of colorectal cancer.

Australia’s engagement with global pharma and medtech firms, and how health research and commercialisation can be fostered, was examined in a report released by MTPConnect during the BIO Convention in Philadelphia last week.

AVITA Medical (ASX:AVH),  a regenerative medicine company with a technology platform designed to address unmet medical needs in therapeutic skin restoration, has announced new preliminary data relating to its RECELL Autologous Cell Harvesting Device.

Melbourne-based Telix Pharmaceuticals (ASX:TLX) has announced the extension of its research collaboration with the Institute for Radiation Sciences (IRS), Osaka University and the Department of Nuclear Medicine and Tracer Kinetics at Osaka University Graduate School of Medicine.

Digital health company ResApp Health (ASX:RAP) has announced it has received $1.785 million from its R&D tax incentive claim for the financial year ending 30 June 2018.